Lizzie Zhang and Dr. Gerry Lipshutz presented at this year’s ASGCT Conference. Lizzie presented “Oligodendrocyte Toxicity by Guanidino Compounds, Not Arginine, Fosters Dysmyelination in Arginase Deficiency and is Prevented by AAV-Based Gene Therapy.” Dr. Lipshutz presented “mRNA-3927 Therapy for Propionic Acidemia: Interim Data From a Phase 1/2 Study.” Congratulations to both Lizzie and Dr. Lipshutz!
Several members of the Lipshutz Lab attended the 26th Annual American Society of Gene and Cell Therapy Conference. These members included Dr. Gerry Lipshutz, Lizzie Zhang, Colleen Le, Natanya Gunn, Taryn Diep, Puja Patel, Yue Huang, and Aleks Bogoniewski.
Dr. Gerald Lipshutz has been awarded the Quest Award by the California Institute for Regenerative Medicine (CIRM)! The $2.3 million award will fund the lab’s work to develop a one-time gene therapy to treat creatine transporter deficiency, which inhibits creatine—a molecule that is an essential energy source for brain and muscle cells—from reaching the brain and muscles and causes neural…
“Mouse Study Shows Gene Therapy May Correct Creatine Deficiency Disorder” Link: https://www.uclahealth.org/news/LipshutzGAMT2022
Andrea, Lizzie, and Colleen attended the 25th Annual American Society of Gene and Cell Therapy (ASGCT) Conference. Lizzie and Colleen presented their research.
Congratulations to Matt on receiving his PhD and starting a new position at Poseida Therapeutics joining Brian Truong!
We are all very excited to have her join our research group!
Matt Nitzahn presented his dissertation project to his committee, family and others interested in his work.
Congratulations to Colleen on her acceptance into the i2URP Program!
Matt, Suhail, and Jenna attended and presented their research at the 23rd Annual American Society of Gene and Cell Therapy (ASGCT) virtual Conference.